Publicaciones en las que colabora con Manuel Alós Almiñana (1)

2024

  1. Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma: Real-life Experience from a Single Tertiary Centre in Spain and ALBI Score as a Survival Prognostic Factor

    Cancer Diagnosis and Prognosis, Vol. 4, Núm. 5, pp. 623-630